{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:30:29Z","timestamp":1793230229215,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37 CA276928"],"award-info":[{"award-number":["R37 CA276928"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1-R03- AG-074068-01A1"],"award-info":[{"award-number":["1-R03- AG-074068-01A1"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}],"id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","award":["P30AG028716"],"award-info":[{"award-number":["P30AG028716"]}],"id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["129784-IRG-16-188-38-IRG"],"award-info":[{"award-number":["129784-IRG-16-188-38-IRG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["R21AG066388"],"award-info":[{"award-number":["R21AG066388"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["R03-AG-074068-01A1"],"award-info":[{"award-number":["R03-AG-074068-01A1"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtct.2024.01.062","type":"journal-article","created":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T04:52:31Z","timestamp":1705812751000},"page":"415.e1-415.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients"],"prefix":"10.1016","volume":"30","author":[{"given":"Anthony D.","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy","family":"Koll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon H.","family":"Gier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Racioppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griffin","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8545-7320","authenticated-orcid":false,"given":"Marcia","family":"Free","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyal","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Bohannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8249-6801","authenticated-orcid":false,"given":"Ernaya J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5399-2782","authenticated-orcid":false,"given":"Bharathi","family":"Selvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria V.","family":"Babushok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3688-9836","authenticated-orcid":false,"given":"Noelle V.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7946-7778","authenticated-orcid":false,"given":"Saar I.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1125-4060","authenticated-orcid":false,"given":"Elizabeth O.","family":"Hexner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7584-6850","authenticated-orcid":false,"given":"MaryEllen","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander E.","family":"Perl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith W.","family":"Pratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina M.","family":"Luger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6725-7220","authenticated-orcid":false,"given":"Nelson J.","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6451-2644","authenticated-orcid":false,"given":"Alfred L.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Stadtmauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison W.","family":"Loren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2513-0533","authenticated-orcid":false,"given":"Vijaya R.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3850-9799","authenticated-orcid":false,"given":"Phyllis A.","family":"Gimotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2813-6781","authenticated-orcid":false,"given":"Shannon R.","family":"McCurdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2024.01.062_bib0001","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1038\/s41375-019-0477-x","article-title":"Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study","volume":"33","author":"Ustun","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2024.01.062_bib0002","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1200\/JCO.20.03380","article-title":"Biologic assignment trial of reduced-intensity hematopoietic cell transplantation based on donor availability in patients 50-75 years of age with advanced myelodysplastic syndrome","volume":"39","author":"Nakamura","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0003","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1200\/JCO.2009.25.4821","article-title":"Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome","volume":"28","author":"McClune","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0004","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.2014.60.4777","article-title":"Outcomes of nonmyeloablative HLA-haploidentical blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in older adults","volume":"33","author":"Kasamon","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0005","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.bbmt.2020.04.013","article-title":"Current use of and trends in hematopoietic cell transplantation in the United States","volume":"26","author":"D'Souza","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0006","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00277-015-2351-x","article-title":"Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States","volume":"94","author":"Medeiros","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0007","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/s41409-018-0164-y","article-title":"Socioeconomic and health system factors associated with lower utilization of hematopoietic cell transplantation in older patients with acute myeloid leukemia","volume":"53","author":"Bhatt","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0008","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1200\/JCO.2015.65.4327","article-title":"Validation of a prediction tool for chemotherapy toxicity in older adults with cancer","volume":"34","author":"Hurria","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0009","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1200\/JCO.2013.54.8347","article-title":"International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer","volume":"32","author":"Wildiers","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0010","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1200\/JOP.18.00180","article-title":"Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO Guideline for Geriatric Oncology Summary","volume":"14","author":"Mohile","year":"2018","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.jtct.2024.01.062_bib0011","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.6004\/jnccn.2021.0043","article-title":"NCCN Guidelines\u00ae Insights: Older Adult Oncology, Version 1.2021","volume":"19","author":"Dotan","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jtct.2024.01.062_bib0012","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jgo.2019.11.008","article-title":"Returning to life activities after hematopoietic cell transplantation in older adults","volume":"11","author":"Koll","year":"2020","journal-title":"J Geriatr Oncol"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2024.01.062_bib0013","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1182\/blood-2018-99-111274","article-title":"The relationship between age and allogeneic hematopoietic stem cell transplantation (HSCT) in a cohort of older patients with acute myeloid leukemia (AML)","volume":"132","author":"Medeiros","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.062_bib0014","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/bloodadvances.2020001719","article-title":"Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes","volume":"4","author":"Olin","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.01.062_bib0015","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jgo.2019.09.012","article-title":"Use of geriatric assessment in hematopoietic cell transplant","volume":"11","author":"Jayani","year":"2020","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0016","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbmt.2012.11.006","article-title":"Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients","volume":"19","author":"Muffly","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0017","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3324\/haematol.2014.103655","article-title":"Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients","volume":"99","author":"Muffly","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2024.01.062_bib0018","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41409-017-0021-4","article-title":"Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis","volume":"53","author":"Deschler","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0019","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jtct.2021.09.002","article-title":"Feasibility and implementation of a multimodal supportive care program to improve outcomes in older patients undergoing allogeneic stem cell transplantation","volume":"27","author":"Szewczyk","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.01.062_bib0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/gerona\/gls119","article-title":"Searching for an operational definition of frailty: a Delphi method- based consensus statement: the Frailty Operative Definition-Consensus Conference project","volume":"68","author":"Rodr\u00edguez-Ma\u00f1as","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jtct.2024.01.062_bib0021","doi-asserted-by":"crossref","first-page":"e9852","DOI":"10.1097\/MD.0000000000009852","article-title":"Frail and pre-frail phenotype is associated with pain in older HIV-infected patients","volume":"97","author":"Petit","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jtct.2024.01.062_bib0022","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/annonc\/mdu540","article-title":"The prevalence and outcomes of frailty in older cancer patients: a systematic review","volume":"26","author":"Handforth","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0023","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(98)04402-X","article-title":"A brief clinical instrument to classify frailty in elderly people","volume":"353","author":"Rockwood","year":"1999","journal-title":"Lancet"},{"issue":"9 Pt 2","key":"10.1016\/j.jtct.2024.01.062_bib0024","first-page":"25S","article-title":"Targeting strategies: an overview of criteria and outcomes","volume":"39","author":"Winograd","year":"1991","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jtct.2024.01.062_bib0025","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jtct.2024.01.062_bib0026","first-page":"389","article-title":"Frailty and cause-specific hospitalization among persons aging with HIV infection and injection drug use","volume":"72","author":"Piggott","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jtct.2024.01.062_bib0027","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jamcollsurg.2010.01.028","article-title":"Frailty as a predictor of surgical outcomes in older patients","volume":"210","author":"Makary","year":"2010","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jtct.2024.01.062_bib0028","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/SLA.0000000000002025","article-title":"Frailty, length of stay, and mortality in kidney transplant recipients a national registry and prospective cohort study","volume":"266","author":"McAdams-DeMarco","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.jtct.2024.01.062_bib0029","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1097\/TP.0000000000002213","article-title":"Frailty, inflammatory markers, and waitlist mortality among patients with end-stage renal disease in a prospective cohort study","volume":"102","author":"McAdams-DeMarco","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2024.01.062_bib0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2018.11.031","article-title":"Chemotherapy in older adult gynecologic oncology patients: can a phenotypic frailty score predict tolerance?","volume":"152","author":"Hay","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0031","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.arr.2015.12.003","article-title":"Frailty assessment instruments: systematic characterization of the uses and contexts of highly-cited instruments","volume":"26","author":"Buta","year":"2016","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.jtct.2024.01.062_bib0032","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1016\/j.bbmt.2019.07.030","article-title":"Hematopoietic cell transplant-related toxicities and mortality in frail recipients","volume":"25","author":"Pamukcuoglu","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0033","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jgo.2021.08.008","article-title":"Serial frailty assessments following allogeneic stem cell transplant in older adults: a pilot study","volume":"13","author":"Ombres","year":"2022","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0034","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.bbmt.2009.02.007","article-title":"Validation of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in single and multiple institutions: limitations and inferences","volume":"15","author":"Sorror","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2022.11.020","article-title":"Expanded HCT-CI definitions capture comorbidity better for younger patients of allogeneic HCT for non-malignant diseases","volume":"29","author":"Broglie","year":"2023","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.01.062_bib0036","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1182\/bloodadvances.2019000155","article-title":"Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70","volume":"3","author":"Imus","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.01.062_bib0037","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41409-022-01833-0","article-title":"A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older","volume":"58","author":"Backhaus","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0038","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/bmt.2008.300","article-title":"Performance status, but not the hematopoietic cell transplantation comorbidity index (HCT-CI), predicts mortality at a Canadian transplant center","volume":"43","author":"Guilfoyle","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0039","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.bbmt.2014.06.005","article-title":"Does the Hematopoietic Cell Transplantation Specific Comorbidity Index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy","volume":"20","author":"Nakaya","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0040","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.bbmt.2011.06.009","article-title":"The Hematopoietic Cell Transplantation-Specific Comorbidity Index fails to predict outcomes in high-risk AML patients undergoing allogeneic transplantation\u2014investigation of potential limitations of the index","volume":"17","author":"Birninger","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0041","series-title":"Evaluation of Chemotherapeutic Agents","author":"MacLeod","year":"1949"},{"key":"10.1016\/j.jtct.2024.01.062_bib0042","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1200\/JCO.1999.17.10.3173","article-title":"Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy","volume":"17","author":"Bajorin","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0043","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.2004.06.132","article-title":"Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma","volume":"22","author":"Motzer","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0044","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1200\/JCO.1991.9.9.1618","article-title":"Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience","volume":"9","author":"Albain","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0045","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbmt.2019.08.022","article-title":"Functional status as measured by geriatric assessment predicts inferior survival in older allogeneic hematopoietic cell transplantation recipients","volume":"26","author":"Huang","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0046","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41409-020-0979-1","article-title":"Pilot prospective study of frailty and functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation","volume":"56","author":"Salas","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0047","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1634\/theoncologist.2015-0200","article-title":"Prognostic importance of pretransplant functional capacity after allogeneic hematopoietic cell transplantation","volume":"20","author":"Jones","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.jtct.2024.01.062_bib0048","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3348\/kjr.2022.0061","article-title":"Restricted mean survival time for survival analysis: a quick guide for clinical researchers","volume":"23","author":"Han","year":"2022","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0049","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.062_bib0050","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1200\/JCO.2016.70.7091","article-title":"Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes","volume":"35","author":"Scott","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2024.01.062_bib0051","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbmt.2016.02.018","article-title":"Recovery of unrelated donors of peripheral blood stem cells versus recovery of unrelated donors of bone marrow: a prespecified analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201","volume":"22","author":"Burns","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl_1","key":"10.1016\/j.jtct.2024.01.062_bib0052","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1182\/blood-2019-124468","article-title":"Fried frailty phenotype predicts mortality for newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome","volume":"134","author":"McCurdy","year":"2019","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2024.01.062_bib0053","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2023-188978","article-title":"Frail and pre-frail older adults with acute myeloid leukemia have inferior survival due to higher rates of disease-related deaths","volume":"142","author":"Hadjis","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2024.01.062_bib0054","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/bloodadvances.2019000790","article-title":"Results from a multidisciplinary clinic guided by geriatric assessment before stem cell transplantation in older adults","volume":"3","author":"Derman","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2024.01.062_bib0055","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ctrv.2013.01.001","article-title":"Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: a systematic review and meta-analysis","volume":"39","author":"Persoon","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jtct.2024.01.062_bib0056","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/bmt.2010.288","article-title":"Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial","volume":"46","author":"Knols","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2024.01.062_bib0057","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jtct.2021.10.018","article-title":"Transplantation for older adults-more questions than answers","volume":"27","author":"McCurdy","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2024.01.062_bib0058","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.jtct.2024.01.062_bib0059","doi-asserted-by":"crossref","first-page":"S407","DOI":"10.1016\/j.jtct.2023.12.575","article-title":"Post-transplant frailty phenotype predicts survival","volume":"30","author":"McCurdy","year":"2024","journal-title":"Transplant Cell Ther"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724001520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636724001520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:59:53Z","timestamp":1778921993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636724001520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2666636724001520"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2024.01.062","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2024.01.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}